Ars Live: The rise of GLP-1 drugs: Insights and Unknowns
Channel:
Subscribers:
385,000
Published on ● Video Link: https://www.youtube.com/watch?v=eLI6dYmtmGo
Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.